Immuneering to Announce Updated Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on September 25

globenewswire

Immuneering to Announce Updated Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on September 25 – NEWSnet – News… as it used to be

More Press Releases

May 4, 2026

Tokyo’s MoN Takanawa: The Museum of Narratives Named One of the World’s Most Beautiful Museums 2026 by the UNESCO-backed Prix Versailles

May 4, 2026

Power Integrations Names Mike Balow Senior Vice President, Worldwide Sales

May 4, 2026

Threat Detection Emerges as a Breakout Use Case for Fiber Networks

May 4, 2026

Immuneering to Announce Updated Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on September 25

Tokyo’s MoN Takanawa: The Museum of Narratives Named One of the World’s Most Beautiful Museums 2026 by the UNESCO-backed Prix Versailles

Power Integrations Names Mike Balow Senior Vice President, Worldwide Sales

Threat Detection Emerges as a Breakout Use Case for Fiber Networks

CoStar’s U.S. Retail Forecast Remains Balanced Through 2026